Correlation Between OncoCyte Corp and ISpecimen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and ISpecimen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and ISpecimen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and iSpecimen, you can compare the effects of market volatilities on OncoCyte Corp and ISpecimen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of ISpecimen. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and ISpecimen.

Diversification Opportunities for OncoCyte Corp and ISpecimen

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between OncoCyte and ISpecimen is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and iSpecimen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iSpecimen and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with ISpecimen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iSpecimen has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and ISpecimen go up and down completely randomly.

Pair Corralation between OncoCyte Corp and ISpecimen

Considering the 90-day investment horizon OncoCyte Corp is expected to under-perform the ISpecimen. But the stock apears to be less risky and, when comparing its historical volatility, OncoCyte Corp is 3.27 times less risky than ISpecimen. The stock trades about -0.09 of its potential returns per unit of risk. The iSpecimen is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  470.00  in iSpecimen on August 29, 2024 and sell it today you would lose (55.00) from holding iSpecimen or give up 11.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OncoCyte Corp  vs.  iSpecimen

 Performance 
       Timeline  
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
iSpecimen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iSpecimen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, ISpecimen is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

OncoCyte Corp and ISpecimen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OncoCyte Corp and ISpecimen

The main advantage of trading using opposite OncoCyte Corp and ISpecimen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, ISpecimen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISpecimen will offset losses from the drop in ISpecimen's long position.
The idea behind OncoCyte Corp and iSpecimen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities